Active Substance & Generic Molecule Directory

Terbinafine Hci in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Terbinafine Hci registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

13
Registered Brands
Availability in Malaysia:11 Prescription (MAL-A)
Showing 13 of 13 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL06091437ARZApo-Terbinafine 250 mg Tablets281.3 mg 0Prescription (MAL-A)PHARMAFORTE (MALAYSIA) SDN. BHD.Compare →
MAL20040824XDERMAFIN CREAM10MGPrescription (MAL-A)Y.S.P. INDUSTRIES (M) SDN. BHD.Compare →
MAL06061541XRLamisil 1% DermGelPrescription (MAL-A)ZUELLIG PHARMA SDN. BHD.Compare →
MAL05092235XRLAMISIL CREAM 1%1 g 100 gPrescription (MAL-A)ZUELLIG PHARMA SDN. BHD.Compare →
MAL07010970XNafine cream 1%w/w1.00 %(w/w)Prescription (MAL-A)PRIME PHARMACEUTICAL SDN. BHD.Compare →
MAL20152470HXENatural Pet Skin & Coat Antifungal Gel0.2gVeterinary (MAL-V)WINWA MEDICAL SDN. BHD.Compare →
MAL20152471HXENatural Pet Skin & Coat Antifungal Lotion0.3gVeterinary (MAL-V)WINWA MEDICAL SDN. BHD.Compare →
MAL08120905AZONCHOFIN 125 (Terbinafine Tablets 125 mg)140.625 mg 0Prescription (MAL-A)UNIMED SDN. BHD.Compare →
MAL08120903AZONCHOFIN 250 (Terbinafine Tablets 250mg)281.250 mg 0Prescription (MAL-A)UNIMED SDN. BHD.Compare →
MAL11110010AZTerbicip 250mg Tablets281.250 mg 0Prescription (MAL-A)CIPLA MALAYSIA SDN BHDCompare →
MAL09100008XTerbin Cream 1%10.00 mg 0Prescription (MAL-A)SM PHARMACEUTICALS SDN. BHD.Compare →
MAL20040748XTERNAFIN CREAM10 MG/GMPrescription (MAL-A)PAHANG PHARMACY SDN. BHD.Compare →
MAL05121149AZTernafin Tablet 250 mg281.30 mg 0Prescription (MAL-A)PAHANG PHARMACY SDN. BHD.Compare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.